Roche Names Warwick S. Bedwell Global Head - Business Development, Pharma Partnering
Roche recently announced the appointment of Warwick S. Bedwell as vice president and global head, Business Development - Pharma Partnering, a part of the Roche pharmaceuticals business devoted to building a world-class network of alliances with emerging biotech companies. Based in Nutley, New Jersey, Bedwell will report to Peter Hug, global head, Roche Pharma Partnering and be responsible for leading Global Business Development, which identifies and assesses partnership opportunities with external companies.
“I am delighted that Warwick has joined our Pharma Partnering senior management team,” said Hug. “His breadth of experience combined with his strategic insight about the dynamics of the industry, particularly in Asia, will be important as we broaden our relationships with potential new partners and strengthen our network of more than 80 partners worldwide.”
Since June 2003, Bedwell had been Roche General Manager for the Philippines. Prior to that, he held several a variety of senior sales and marketing positions across the primary care and specialty care portfolios in Australia. Before joining Roche in 1998, Bedwell held positions of increasing responsibility at Schering-Plough in Australia and Asia and other healthcare related companies in Australia.
“Roche is clearly a leader in creating valuable strategic alliances,” said Bedwell. “I greatly appreciate the opportunity to join the Pharma Partnering team and help enhance the Roche partnering model, which is becoming an industry standard.”
Since 2006, Bedwell has been a member of the Board of European Chamber of Commerce of the Philippines and the Pharmaceutical and Healthcare Association of The Philippines. He is also a member of the Pharmaceutical Society of Australia and the Australian College of Pharmacy Practice.
Bedwell received a Bachelor of Pharmacy Degree from the University of Sydney, Australia, and a Masters in Business Administration and a Post-Graduate Diploma in Marketing from the University of Technology, Sydney, Australia. Registered in Australia as a pharmacist, Bedwell is married and has two children.
Hoffmann-La Roche Inc. (Roche), based in Nutley, N.J., is the U.S. pharmaceuticals headquarters of the Roche Group, one of the world’s leading research-oriented healthcare groups with core businesses in pharmaceuticals and diagnostics. For more than 100 years, the Roche Group has been committed to developing innovative products and services that address prevention, diagnosis and treatment of diseases, thus enhancing people’s health and quality of life. An employer of choice, in 2006, Roche was named one of the Top 20 Employers (Science magazine), ranked the No. 1 Company to Sell For (Selling Power), and one of AARP’s Top Companies for Older Workers, and in 2005, Roche was named one of Fortune magazine’s Best Companies to Work For in America. For additional information about the U.S. pharmaceuticals business, visit our websites: http://www.rocheusa.com or www.roche.us.
This news content was configured by WebWire editorial staff. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.